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Abstract Background and aim Functional Capacity
Evaluations (FCEs) are used to quantify physical aspects of
work capacity. Safety is a critical issue for clinical use of
an FCE. Patients with Chronic Low Back Pain (CLBP) are
known to report a temporary increase in pain following an
FCE, but it is not known whether this increase is a normal
pain response to FCE. It is currently unknown how healthy
subjects respond to an FCE and whether this should be
interpreted as a normal reaction after physical exercise.
This study was performed to quantify the intensity, dura-
tion, location and nature of the pain response following an
FCE in healthy subjects and to compare this pain response
with the pain response of patients with CLBP from a pre-
vious study. Methods A total of 197 healthy working
subjects between 20 and 60 years of age volunteered to
participate in this study. All subjects performed a 12-item
FCE. Pain response was measured by a self-constructed
Pain Response Questionnaire (PRQ). Descriptive statistics
were used to describe the pain response following an FCE.
Mann–Whitney and t-tests were performed to compare the
data from this study with data of patients with CLBP from
a previous study. Results About 82% of all subjects
reported a pain response following the FCE. The intensity
of the pain response after 24 h post FCE was a median of
3.0 on a numeric rating scale (0–10). About 78% of all pain
was reducible to muscle soreness. Pain was most often
reported in the upper legs (51%), the lower back (38%) the
shoulders (37%) and upper arms (36%). Symptoms
decreased to pre-FCE levels in a mean of 3 days. The pain
response of 2 subjects (1%) lasted for 3 weeks. The
intensity and duration of the pain response of healthy
subjects was not signiﬁcantly different from the response of
patients with CLBP. Conclusion Pain response of 99% of
all subjects who reported a pain response was interpreted as
normal. It was concluded that a pain response following an
FCE can be expected in healthy subjects and that this pain
response is a normal musculoskeletal reaction. The pain
response of patients with CLBP resembles the pain
response of healthy subjects.
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Introduction
Functional Capacity Evaluations (FCEs) are sets of func-
tional tests to measure the ability to perform work-related
activities. FCEs are used in occupational rehabilitation,
return to work determinations, disability determinations
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guidelines and demands for clinical use of FCE with
regards to safety, reliability, validity, practicality and util-
ity. Validity and reliability of FCE have been addressed,
[2] but safety has scarcely been addressed so far. Five
studies reported about the safety of FCE [3–7]. One study
suggested that safety can be monitored in three main areas:
physiological (heart rate and blood pressure), biomechan-
ical (muscle fatigue or weakness) and psychophysical (pain
or fear of re-injury) [3]. The outcome of this study was that
the FCE could be administered safely when these safety
issues are carefully taken into account and if the recom-
mended guidelines, as provided by the US National
Institute for Occupational Safety and Health (NIOSH) [8]
are applied to minimize the risk of further or other injury
[3]. The California Functional Capacity Protocol (Cal FCP)
was found to be a safe protocol because no new injuries or
exacerbations of current impairments were reported in a
study sample of 64 patients suffering from soft tissue
musculoskeletal injuries [4]. A study, in which the devel-
opment of the EPIC Lift Capacity (ELC) test was
described, reported this test to be safe based on 687 tests in
healthy and disabled subjects because no incidents were
reported. Several healthy subjects however reported next-
day symptoms which were identiﬁed as soreness [5].
Others concluded that FCE appeared to be safe in patients
with Chronic Low Back Pain (CLBP) because no injury
reports had been ﬁled and the pain decreased to pre FCE
levels [6]. The study lacked normative data to compare the
results to. It was suggested that further research should
focus on operational deﬁnitions for injury, in order to test
the safety of FCE. In a study in which FCE lifting results
were compared with the NIOSH recommended safe weight
lifting (RWL), it was observed that the RWL of the NIOSH
and the FCE lifting results differed substantially [7]. It is
unclear which outcome could be used as a RWL of safe
lifting. Additional research into safety and operational
deﬁnitions of injury are needed to test these contrary
ﬁndings.
Safety in FCE is a key issue because kinesiophysical
FCEs demand a patients’ maximum physical effort [9]. A
normal physical response during maximum physical effort
includes an increase in heart rate, systolic blood pressure,
body temperature, sweat secretion and breath frequency
[10]. Besides this, delayed onset muscles soreness (DOMS)
after intensive and uncommon exercising is a normal
reaction of the musculoskeletal system [11]. It is currently
not known how healthy workers respond to an FCE and
therefore unknown what should be considered to be a
normal pain response. Consequently, it is difﬁcult to clin-
ically interpret the pain increase in patients following an
FCE. If the pain response in healthy subjects is known, a
comparison can be made between the pain response of
healthy subjects and the pain response of patients.
The objectives of this study were to quantify the loca-
tion, intensity, duration and nature of the pain response in
healthy subjects following a 12-item FCE. The second goal
of this study was to explore differences and similarities
between the data from this study and data from patient
reports used in a previous study [6]. In the current study, an
FCE was considered safe when the FCE does not lead to
injuries and when the pain response is considered to be
normal. According to the physiology literature, a pain
response was considered normal when symptoms increased
within the ﬁrst 24 h following FCE, peaked between 24
and 72 h and subsided and disappeared within 5–7 days
after the FCE [11]. Any response not following this deﬁ-
nition was interpreted as an abnormal response.
Methods
Subjects
A total of 232 healthy adults working in a broad range of
jobs voluntarily participated in this study. Subjects were
recruited via local press and personal networks. Subjects
were included after providing informed consent and sign-
ing a statement of good health, when meeting the criteria of
the Physical Activity Readiness-Questionnaire (PAR-Q)
[12, 13], and when they were between 20 and 60 years of
age and worked at least 20 h per week for the last year.
Excluded were subjects who had been absent from work
for more than 2 weeks because of dysfunction of the
musculoskeletal system during the year prior to FCE, or
subjects whose blood pressure in rest exceeded 159 mmHg
(systolic) or 100 mmHg (diastolic) [14].
Procedures
Prior to the FCE, subjects ﬁlled in a questionnaire to obtain
demographic information, a Pain Response Questionnaire
and the PAR-Q. Subjects performed a 2 h, 12-item FCE
(see Table 1). After an introduction to general FCE pro-
cedures, subjects were brieﬂy instructed how to perform
each individual test. Each test was ﬁrst demonstrated by the
evaluator. Subjects were allowed to start the next test when
the heart rate (HR) was below 70% of the age related
maximum HR (220-age). Subjects received instructions on
how to use the Borg CR-10 scale which was used for
measurement of perceived exertion after each test [15, 16].
Subjects were individually evaluated by 1 of 15 physio-
therapy students who had completed a 2-day FCE-training.
This study was approved by the Medical Ethical
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123Committee of the University Medical Center Groningen,
the Netherlands.
Endpoints
Tests could be terminated for three endpoints [3]: cardiac,
biomechanical and subject endpoints. Cardiac endpoint
was reached when HR was above 85% of age related
maximum. HR was measured with a heart rate monitor.
Biomechanical endpoints were: loss of solid standing basis
during lifting tasks or loss of control of the load. Biome-
chanical endpoints were determined by the evaluators.
Subject endpoints were reached when subjects stopped the
test. Subjects were instructed to stop at any point if they
wished to do so.
Pain Response Questionnaire
A Pain Response Questionnaire (PRQ; Appendix 1) was
developed to obtain information about the pain response
prior to FCE and 7 days following FCE, medication use
following the FCE and to control for unusual or heavy
physical activity in days following the FCE. The intensity
of the pain response was measured by an 11-point numeric
rating scale (NRS) for pain ranging from ‘0’ (no pain) to
‘10’ (worst pain imaginable) for 17 body parts separately
[20]. Subjects were asked whether their pain score was
reducible to muscle soreness, of a different origin, a
combination of these, or whether the origin of pain was
considered unknown. The PRQ was ﬁlled in by the subjects
just prior to the FCE, directly following the FCE and was
taken home to ﬁll in for at least on three consecutive days
after the FCE to a maximum of 7 days. Subjects were
asked to ﬁll in the PRQ on the days following the FCE after
13.00 h. The PRQ could be returned in a reply-paid
envelope if pain was no longer reported or when the
maximum of 7 days had been reached. The PRQ was pilot
tested in 14 healthy subjects [21] and was found suitable
for testing. None of the 14 subjects reported a response
longer than 7 days in this pilot study.
Table 1 Content of the FCE
Test Procedure Performance
category
References
1 Lifting ﬂoor to table 5 lifts of a weighted crate from table to ﬂoor v.v.; 4–5 weight increments
until maximum lifting capacity is reached;\90 s Maximum performance
was recorded (kg).
Strength [17]
2 Lifting table to crown height 5 lifts from table to crown height v.v.; 4–5 weight increments until maximum
is reached;\90 s Maximum performance was recorded (kg).
Strength [17, 18]
3 Long carry two handed Carry 20 m; waist height; 4–5 weight increments until maximum is reached;
\90 s Maximum performance was recorded (kg).
Strength [17]
4 Overhead work test (loaded) Standing with hands at crown height; manipulating nut/bolts, wrists are
loaded with 1 kg cuff weight. Duration was recorded (sec).
Postural
tolerance
[18]
5 Forward bend test standing
(loaded)
Standing with 30–60 trunk ﬂexion; Manipulating nut/bolts, upper back is
loaded with a weight of 5 kg. Duration was recorded (sec).
Postural
tolerance
[17]
6 Dynamic bending test Fast repetitive bending at hips and back; remove small object from ﬂoor to
crown height; 20 reps. Time to complete 20 reps was recorded (sec).
Repetitive work [17]
7 Repetitive side reaching test Remove object horizontally at table height from right to left with right hand/
arm and vice versa; distance: wing span; 30 reps.; sitting. Time to
complete 30 reps was recorded (sec).
Repetitive work [17, 18]
8 Hand grip strength test In a seated position; the elbow ﬂexed at 90; grip strength of the right and left
hand was measured in a three trial procedure; ﬁve different handgrip
positions. Mean performance was recorded (kgF).
Strength [17, 18]
9 Finger strength test In a seated position; the elbow ﬂexed at 90; tip, key and palmar pinch
strength of the ﬁngers was measured in a three trial procedure; left/right.
Mean performance was recorded (kgF).
Strength [17, 18]
10 Purdue pegboard task In a seated position; placing pins with one hand as fast as possible in a three
trial procedure; left/right. Mean number of pins per 30 s was recorded.
Coordination [17, 18]
11 Complete Minnesota
dexterity test
In a seated position; displacing 59 blocks in a pre determined way with left
and right hand as fast as possible in a four trial procedure. Time to
complete 4 trials was recorded (sec).
Coordination [17, 18]
12 Treadmill ergometry The subject walks/runs on a treadmill to 85% of HR max. At timed stages of
three minutes the speed and grade of slope of the treadmill are increased
(Bruce protocol). Time to reach 85% of HR max was recorded and
transformed into VO2 max value (ml/min/kg).
Endurance [19]
292 J Occup Rehabil (2008) 18:290–298
123Data Analyses
Descriptive statistics were used to describe the subject
characteristics and pain response. Box plots were made
because the data of pain intensity was not normally distrib-
uted.Tobeabletocomparedataofhealthysubjectswithdata
ofpatientswith chronic low back pain froma previous study
[6], independent samples Mann–Whitney and t-tests were
performed. Results were considered statistically signiﬁcant
when P\0.05. A Bonferroni correction was applied to
reduce type 1 error (P = a/n = 0.006 for signiﬁcance).
Results
A total of 35 subjects of the original group of 232 volun-
teers were excluded from analyses because they did not
meet the inclusion criteria (n = 20), did not return the PRQ
(n = 8) or because they resigned to participate after all
(n = 7). Included were 197 subjects (102 males and 95
females), whose data were used for analyses. Subject
characteristics are presented in Table 2.
Pain Response
A total of 162 subjects (82%) reported a pain response
following the FCE. 53 subjects reported pain prior to the
FCE and 57 subjects reported pain directly after the FCE.
Descriptive statistics of the origin and intensity of the pain
of the main body parts are presented in Table 3. Because
most subjects reported their maximum pain intensity on the
ﬁrst day following the FCE, Table 3 reﬂects the status 24 h
following the FCE. Most often, a pain response was
reported in the upper legs (51%), the lower back (38%) and
the upper arm (37%) and shoulders (36%). The location of
the pain response of the 17 main body regions is presented
in Fig. 1. The intensity of the pain over time from pre FCE
level to the next 7 days following the FCE is presented in
Fig. 2. Figure 2 demonstrates that the highest pain
Table 2 Subject characteristics
(n = 197; 102 men, 95 women)
Yrs = years; cm = centimeter;
kg = kilogram
a Low = primary school unﬁn-
ished and ﬁnished;
intermediate = secondary
school and junior; college;
high = bachelor’s degree and
university
Mean (SD)
Age (yrs) 40.8 (10.5)
Body length (cm) 176.4 (9.4)
Body weight (kg) 73.4 (12.4)
Hours working
per week
34.9 (8.2)
Education
a n
Low 16
Intermediate 48
High 129
Other 4
Table 3 Description of intensity, location and origin of pain for those subjects who reported pain 24 h following FCE (n = 162)
Location Pain response
%( n)
Mean (SD)
pain intensity
Origin of pain (self report)
DOMS % (n) Other % (n) Both % (n) Unknown % (n)
Any location (max pain) 82 (162) 3.0 (2.4) n/a n/a n/a n/a
Neck 24 (49) 2.9 (1.9) 78 (39) 2 (1) 6 (3) 12 (6)
Shoulders 36 (73) 3.1 (1.7) 80 (58) 1 (1) 6 (4) 14 (10)
Upper arm 37 (75) 2.7 (1.4) 83 (62) 4 (3) 0 (0) 13 (10)
Elbow 7 (15) 3.0 (1.6) 60 (9) 13 (2) 7 (1) 20 (3)
Lower arm 12 (25) 2.4 (1.6) 84 (21) 0 (0) 0 (0) 16 (4)
Wrists 4 (9) 2.4 (1.2) 56 (5) 33 (3) 0 (0) 11 (1)
Hand 5 (11) 2.6 (1.9) 73 (8) 0 (0) 0 (0) 27 (3)
Chest 1 (2) 5.0 (1.4) 100 (2) 0 (0) 0 (0) 0 (0)
Upper back 19 (39) 3.4 (2.0) 92 (36) 0 (0) 3 (1) 5 (2)
Lower back 38 (77) 3.6 (2.0) 81 (62) 7 (5) 4 (3) 9 (7)
Buttocks 15 (30) 3.1 (2.0) 93 (28) 7 (2) 0 (0) 0 (0)
Belly 3 (6) 2.3 (1.7) 67 (4) 0 (0) 0 (0) 33 (2)
Upper leg 51 (103) 3.3 (1.9) 88 (91) 2 (2) 1 (1) 9 (9)
Knee 4 (9) 3.1 (3.0) 33 (3) 33 (3) 0 (0) 33 (3)
Lower leg 12 (25) 2.1 (1.2) 88 (22) 8 (2) 0 (0) 4 (1)
Ankle 2 (4) 2.0 (0.8) 75 (3) 0 (0) 0 (0) 25 (1)
Foot 1 (2) 1.0 (0.0) 0 (0) 0 (0) 0 (0) 100 (2)
n: number of subjects reporting a response. n/a: not applicable due to reports of pain responses on more than one body region. DOMS: Delayed
Onset Muscle Soreness: Other: pain other than muscle soreness. Both: a combination of muscle soreness and other. Unknown: origin of pain is
unknown
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123response occurred within 24 h following the FCE with a
median pain intensity of 3 on a 0–10 NRS. The pain had
returned to pre-FCE levels 3 days post FCE. A total of 35
subjects (18%) reported a pain intensity over 2.5 9 the
interquartile range (IQR) above the median (Fig. 2) which
was not expected in a population with a normal distribu-
tion. Additional analyses were performed to explore
whether different individual health related characteristics
could be identiﬁed to explain a high pain response. Results
are presented in Table 4. A total of 35 subjects reported a
value over 2.5 x IQR above the median on pain intensity.
This group scores lower on vitality, general health per-
ception and social functioning. A pain response lasting
longer than 7 days was reported by 2 subjects (1%). One
subject reported low back pain which lasted for 22 days.
After a medical consultation of an independent physician
by telephone it was concluded that these symptoms were
non-speciﬁc of origin. After 22 days the person involved
had fully recovered. The other subject was diagnosed with
a ‘trigger-ﬁnger’. These complaints lasted for 21 days until
full recovery. All other values over 2.5 9 IQR above the
median had recovered to pre-FCE level within 7 days
following FCE. Four subjects reported to have used non-
steroidal non-prescriptive pain medication following the
FCE. One subject used a homeopathic ointment. All of
these subjects had stopped their medication use 3 days
following FCE. One subject has used a massage as a means
of coping with post FCE pain response.
Comparison with Patients with CLBP
Table 5 lists the descriptives of former research in patients
with CLBP [6] being compared to the data of healthy
subjects in the current study. To enable comparison of both
datasets on pain intensity, scores from the PRQ were
transformed to a 3-point scale (pain decrease, no differ-
ence, pain increase). No signiﬁcant differences in pain
increase were found between healthy subjects and patients
with CLBP (Table 5). Independent t-tests show that dif-
ferences in the duration of the pain response between
patients with CLBP and healthy subjects were not signiﬁ-
cant (Table 5).
Fig. 1 Location of the pain
response expressed in
percentage of subjects
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123Discussion
The results of this study show that the pain response in
healthy subjects followed a pattern which resembles nor-
mal exercise physiology [10]. The group of subjects in this
study can be generalized to the Dutch population because
personal characteristics such as gender, length, weight and
health perception resemble the Dutch population (Tables 2
and 4). The three domains Pain, Physical Functioning and
Role limitation (physical) of the RAND-36 however differ
clinically from the Dutch population (Table 4). This may
be due to the inclusion criteria of this study; only healthy
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10 
8 
6 
4 
2 
0 
4 
4 
3 
4 
4
4
4 4   
2 
2 
2
2 
2 
3 
3 
2 1   
1
1
1
1 
1 
1
1 
1
1 
Time 
-
 
0
 
(
 
 
 
S
 
R
 
N
 
 
 
n
 
o
 
 
 
y
 
t
 
i
 
s
 
n
 
e
 
t
 
n
 
i
 
 
 
n
 
i
 
a
 
P
 
3
3
3
3 
3 
3 
3 
3 
3 
3 
Fig. 2 Boxplots of the median
concerning the reported pain
response per day. Bold
horizontal lines: medians. Gray
boxes: interquartile range (+ and
-25% of median). Vertical tick
marks: 1.5 9 interquartile
range. Stars: value over
2.5 9 IQR above the median.
Numbers: number of subjects
Table 4 Descriptives of
RAND-36 and t-tests of
differences on the RAND-36
between subgroups 1 and 2
Subgroup 1: subjects reporting
pain intensity less than
2.5 9 IQR. Subgroup 2:
Subjects reporting over
2.5 9 IQR above the median
pain intensity
SD: standard deviation; IQR:
interquartile range
Scale Subjects
Mean (SD);
n = 197
Normative data
of Dutch population
(n = 1063) [22]
Group 1
mean (SD);
n = 162
Group 2
Mean (SD);
n =3 5
t-value (P)
Vitality 66.0 (13.0) 67.4 (19.9) 67.0 (12.2) 62.0 (15.3) 2.1 (0.04)
Mental health 70.4 (10.7) 76.8 (18.4) 71.1 (10.1) 67.6 (13.1) 1.7 (0.09)
Social functioning 90.1 (15.1) 86.9 (20.5) 91.8 (12.2) 83.3 (22.5) 2.1 (0.04)
General health perception 75.5 (16.5) 72.7 (22.7) 76.7 (15.9) 70.3 (18.1) 2.1 (0.04)
Pain 91.6 (12.2) 79.5 (25.6) 92.1 (12.4) 89.3 (11.4) 1.2 (0.22)
Role limitation (emotional) 91.2 (25.8) 84.1 (32.3) 93.2 (23.1) 81.9 (34.6) 1.85 (0.07)
Role limitation (physical) 94.2 (17.4) 79.4 (35.5) 94.1 (17.9) 94.5 (15.2) -0.1 (0.90)
Physical functioning 96.5 (7.0) 81.9 (23.2) 96.7 (7.1) 95.9 (6.4) 0.65 (0.52)
Health change 53.5 (15.4) 52.4 (19.4) 54.0 (15.3) 51.4 (16.0) 0.87 (0.39)
Table 5 Independent t-test and Mann–Whitney test of the differences of pain intensity and duration between patients with CLBP (n = 54) [6]
and healthy subjects (n = 197)
Comparison of pain duration Comparison of pain intensity
Duration pain increase
mean days (SD)
Mean
difference
t-value
(P)
95% CI Pain decreased
n (%)
No difference
n (%)
Pain increased
n (%)
Z( P)
CLBP 3.7 (3.4) 0.7 -1.2 (0.23) -1.95 to 4.81 2 (4) 11 (21) 41 (76) -1.13 (0.26)
Healthy subjects 3.0 (2.5) 15 (8) 48 (24) 134 (68)
95% CI: 95% conﬁdence interval
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123working subjects between 20 and 60 years of age were
included, who had no dysfunction of the musculoskeletal
system at the time of FCE. There were 53 subjects who
reported pain prior to the FCE while stating that they were
without complaints when they signed informed consent. In
total there were 35 subjects who reported a value over
2.5 9 IQR above the median on pain intensity partly
because they reported a pain response prior to the FCE.
Post hoc analyses of personal characteristics reveal that 2
sub-groups may have been included in this study, namely a
group who rated their pain over 2.5 9 IQR above the
median, and a group who rated their pain under 2.5 9 IQR
above the median. Table 4 illustrates that the group who
rated their pain over 2.5 9 IQR above the median scores
lower on vitality, general health perception and social
functioning but not on pain and physical functioning. When
we take into consideration the point-prevalence of mus-
culoskeletal pain in the Dutch population (53.9%) than, of
this population, 70% reports no limitation in daily life
resulting from musculoskeletal pain [23]. This means there
is a large number of persons in the Dutch population who
do experience pain but are not restricted in daily life
activities. The data of the current study may possibly have
included a part of this group. Thus, with regards to pain
status and self reported ADL functioning, the subjects of
this study appear similar to the open Dutch population.
Consequently, the general pattern and diversity of the pain
response as seen in this study should be considered to be a
normal response rather than an indication of injury. There
were two subjects (1%) in this study who reported an
abnormal reaction. However, it remains unknown whether
this may be expected in a normal population after intensive
exercise. The 1-week incidence of neck and back pain,
calculated by The Dutch National Institute for Public
Health and the Environment (RIVM), of the Dutch popu-
lation is 0.15% for men and 0.18% for women [24]. Data
concerning the incidence of musculoskeletal complaints
after intensive exercise such as an FCE is unavailable but is
presumed to be higher.
The second goal of this study was to investigate whether
the pain response of healthy subjects is different from the
pain response of patients with CLBP. Earlier research of the
pain response of patients with CLBP [6] reported a pain
increase in 76% of the subjects, which lasted for a mean of
3.4 days after the FCE. In our study we found a symptom
increase in 82% of all subjects and a normalization of pain
to pre-FCE levels on the third day following the FCE
(Fig. 2). Differences between our study and the patient
study [6] were non signiﬁcant for the pain intensity increase
as well as for duration of the pain increase (Table 5).
However some differences in study design must be taken
into account before drawing such a conclusion. The ﬁrst
concerns the content of the FCE. Our study included an
additional treadmill ergometer test which may have led to a
difference in pain response. The second difference concerns
the patient characteristics. There was a difference in male/
female distribution in both studies. Post hoc analyses show
a signiﬁcant gender difference of 1.3 on pain intensity
measured by the PRQ on the ﬁrst day following the FCE.
Female subjects are slightly ‘‘statistically signiﬁcant’’
reporting more pain. Other possible characteristics of sub-
jects may have led to differences between the studies. This,
however, is beyond the scope of this paper and will be
reported separately. Overall it can be said that the pain
response of healthy subjects in this study appear similar to
patient data [6]. Additionally, former research to the Cal
FPC and the ELC test showed similar results and demon-
strated safety of these protocols [4, 5]. These protocols
however differed substantially from the protocol used in
this study. The FPC and the ELC protocols are based on
psychophysical principles in which a patient determines his/
her own acceptable maximum effort. The protocols used in
this study are based on kinesiophysical principles in which
the evaluator also determines maximal safe effort. Former
research into differences between both the psychophysical
and kinesiophysical approaches has found differences
between outcomes [25]. It appears, however, that when
concerning safety, both the psychophysical and the kine-
siophysical evaluations can be administered safely.
Aweaknessofthisstudywasthatnocorrectionwasmade
for pain responses after different exercises besides the FCE
or for pain prior to the FCE. This has not been done because
causality is not always clear. For example, if a subject
reports a pain intensity of 2 on the PRQ on the ﬁrst day
following the FCE and has an intensive exercise afterwards,
heorshemightreportapainintensityof5thedayfollowing.
Inthisexampleitisunclearwhethertheresponseiscausalto
the FCE or to any activity besides the FCE. On the other
hand, all responses were reported in this study and the real
pain intensity following the FCE could, therefore, be an
overestimation. A total of 53 subjects reported pain before
theFCEand57subjectsreportedpaindirectlyaftertheFCE.
It is remarkable that on an average, subjects reported a
higher level of pain before undergoing the FCE than 4 days
following the FCE. A reason for this might be that subjects
are focused on the severity of pain they feel before the FCE
and/orthattheyarejustreportingaboutthepaintheythinkis
causal to the FCE on the days following the FCE.
The NIOSH guidelines are safety guidelines for recom-
mendation of safe lifting. Former research to the concurrent
validity between the WorkWell FCE lifting task and the
NIOSH Recommend Weight Lift showed signiﬁcant dif-
ferences between both safe lifting recommendations in
patients with CLBP [7]. Patients lifted on average 15 kg
more on the WorkWell FCE lifting task than on the NIOSH
RWL. It was however unknown whether the lifting tasks in
296 J Occup Rehabil (2008) 18:290–298
123the FCE could be administered safely, because data is
lacking with regards to normative data of healthy subjects
and it was unknown whether the pain responses in patients
with CLBP were considered abnormal or normal. The
normative data in the current study is therefore additional to
the question whether the FCE can be administered safely.
This study indicates that an FCE can be administered safely
if all safety procedures are followed.
In conclusion, the pain response of most healthy subjects
(99%) was interpreted as a normal physiological reaction
of the musculoskeletal system after intensive exercise such
as an FCE. 1% of the subjects reported an abnormal
reaction. For a clinician the data from this study is of
concern because it means that a pain response can be
expected and considered normal after an FCE. Healthy
workers and patients should be informed that a pain
response can be expected and that this should in the vast
majority of the cases be interpreted as a normal reaction of
the musculoskeletal system after intensive exercise.
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Pain Response Questionnaire 
Date: ..…- …-……. :  (Day 0 - Pre FCE)       Time: ________      Subject number: 
1.    
Did you experience pain in the last 12 hours?
No    Go to question 2 and 3. 
Yes  Complete the questionnaire 
Instructions for filling in the table
Column 1:   circle every painful body part. 
Column 2:   circle your pain intensity  (0 = ‘no pain’ ; 10 = ‘worst pain imaginable’). 
Column 3:   circle the origin of the pain (both  = muscle soreness and another origin; ? = 
origin is unknown) 
Column 1 
Body part 
Column 2 
0 = ‘no pain’      10 = ‘Worst imaginable pain’  
Column 3 
‘Origin of the pain’ 
Neck 0 1 2 3 4 5 6 7 8  9  10 Muscle soreness  other both    ?
Shoulder  0 1 2 3 4 5 6 7 8  9  10 Muscle soreness  other both ?
Upper arm  0 1 2 3 4 5 6 7 8  9  10 Muscle soreness  other both ?
Elbow 0 1 2 3 4 5 6 7 8  9  10 Muscle soreness  other both ?
Under arm  0 1 2 3 4 5 6 7 8  9  10 Muscle soreness  other both ?
Wrist 0 1 2 3 4 5 6 7 8  9  10 Muscle soreness  other both ?
Hand  0 1 2 3 4 5 6 7 8  9  10 Muscle soreness  other both ?
Chest  0 1 2 3 4 5 6 7 8  9  10 Muscle soreness  other both ?
Upper back  0 1 2 3 4 5 6 7 8  9  10 Muscle soreness  other both ?
Lower back  0 1 2 3 4 5 6 7 8  9  10 Muscle soreness  other both ?
Belly 0 1 2 3 4 5 6 7 8  9  10 Muscle soreness  other both ?
Buttocks  0 1 2 3 4 5 6 7 8  9  10 Muscle soreness  other both ?
Upper leg   0 1 2 3 4 5 6 7 8  9  10 Muscle soreness  other both ?
Knee 0 1 2 3 4 5 6 7 8  9  10 Muscle soreness  other both ?
Lower leg  0 1 2 3 4 5 6 7 8  9  10 Muscle soreness  other both ?
Ankle  0 1 2 3 4 5 6 7 8  9  10 Muscle soreness  other both ?
Foot 0 1 2 3 4 5 6 7 8  9  10 Muscle soreness  other both ?
Different:  
…
0 1 2 3 4 5 6 7 8 9  10 Muscle soreness  other  both ?
2.    
Did you perform any heavy or unusual physical activity in the past 24 hours?
NO  
YES    If yes, please describe the physical activity: 
3.
Did you experience any other physical reactions which were not addressed yet?  
NO
YES     Namely … 
4.
  Did you use any medication following the FCE? 
NO
  YES          Name  medication:      
                        Dose:
Appendix 1: Pain Response Questionnaire
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